Exonate: Dr. Rafiq Hasan Appointed As Non-Executive Director
28 May 2024 //
BUSINESSWIRE
Exonate launches diabetic macular oedema trial
05 Feb 2021 //
PHARMATIMES
Exonate announces the initiation of Phase Ib/II clinical trial
02 Feb 2021 //
GLOBENEWSWIRE
Exonate in collaboration with Janssen patient in ph Ib/II trial for EXN 407
02 Feb 2021 //
PHARMABIZ